Skip to content

Mobile phone-based self-care in diabetic patients

To assess the effectiveness of the education based on the Idia application on the self-care behaviors of the elderly with type 2 diabetes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170611034454N5
Enrollment
102
Registered
2023-08-15
Start date
2023-07-21
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: After selecting the participants of the intervention group, they are invited to visit the Mustafavian diabetes clinic in Sari. In this meeting, the researcher will

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 60 years and above Ability to communicate Having a normal cognitive status based on the cognitive status assessment tool (AMT) (scoring 7 and above) Informed consent of the patient to participate in the study Access to a smart mobile phone and the ability to work with it Internet access Literacy for reading and writing Diagnosed with diabetes by a doctor who has been diagnosed for at least 6 months

Exclusion criteria

Exclusion criteria: using care software before entering the study Unwillingness to participate in the study

Design outcomes

Primary

MeasureTime frame
Self-care score in the Summary of Diabetes Self Care Activities questionnaire. Timepoint: Measuring the self-care score at the beginning of the study (before the start of the intervention) and 1 and 3 months after the start of the intervention. Method of measurement: Summary of Diabetes Self Care Activities questionnaire.

Secondary

MeasureTime frame
HbA1c. Timepoint: At the beginning of the study (before the start of the intervention) and 1 and 3 months after the start of the intervention. Method of measurement: It will be measured by Tobi Sari laboratory kits.;Fasting blood sugar. Timepoint: At the beginning of the study (before the start of the intervention) and 1 and 3 months after the start of the intervention. Method of measurement: Glucometer brand DIABAN and model SMM1000 made in Iran.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhteram Sadat Ilali

Mazandaran University of Medical Sciences

paradis2082000@yahoo.com+98 11 3329 4601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026